Glazer Capital, Llc - 28 May 2025 SCHEDULE 13G Report for Inozyme Pharma, Inc. Common stock, par value $0.0001 per share (INZY)

Filing Manager: Glazer Capital, Llc
Reporting Manager: Glazer Capital, LLC
Security: Inozyme Pharma, Inc. Common stock, par value $0.0001 per share
Symbol: INZY
Shares outstanding: 64.5M shares
Disclosed Ownership: 4.25M shares
Ownership: 6.59%
Form type: SCHEDULE 13G
Filing time: 04 Jun 2025, 17:09:30
Date of event: 28 May 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Glazer Capital, LLC	6.59%	4.25M	0	4.25M	Paul J. Glazer	Paul J. Glazer, Managing Member
Paul J. Glazer	6.59%	4.25M	0	4.25M	Paul J. Glazer	Paul J. Glazer